Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Parent Project Muscular Dystrophy

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 7
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.12
Exits 2
Key employees Soon

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Pharmaceutical
  • Medical
Summary

Among the most successful fund investment fields, there are Medical, Health Care. Among the most popular portfolio startups of the fund, we may highlight Tivorsan Pharmaceuticals, Prosensa. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The typical case for the fund is to invest in rounds with 1 participant. Despite the Parent Project Muscular Dystrophy, startups are often financed by Idinvest Partners, Gimv, Prosensa.

The increased amount of exits for fund were in 2013. Deals in the range of 100 thousands - 1 million dollars are the general things for fund. The high activity for fund was in 2012. The fund is generally included in less than 2 deals every year.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Parent Project Muscular Dystrophy:
Typical Co-investors
Parent Project Muscular Dystrophy is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Parent Project Muscular Dystrophy:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Antares Capital Florida, Miami, United States
AshHill Biomedical Cincinnati, Ohio, United States
AWV Partners -
Binhai China, Guangdong, Guangzhou
Campus Fund -
China Life APM Asset Management Beijing, Beijing, China
Coherent California, Santa Clara, United States
CommonSpirit -
Die Wirtschaftskammer Austria, Vienna
DST Systems Kansas City, Missouri, United States
Formica Ventures -
FusionX Ventures California, San Diego, United States
Infinity Equity China, Hong Kong, Hong Kong Island
Kaedan Capital Israel, Tel Aviv, Tel Aviv
Kedaara Capital India, Maharashtra, Mumbai
San Diego Venture Partners -
Shenzhenshi Huaxia Dexin Jijin Guanli Youxian Gongsi China, Guangdong Province, Huizhou
Sunbo Angel Partners Busan, Pusan-jikhalsi, South Korea
Yihui Invesment Management China, Jiangshan, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Myosana Therapeutics

Biotechnology
Therapeutics
$5M07 Dec 2022 Seattle, Washington, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Parent Project Muscular Dystrophy?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 8
Average round size 1M
Peak activity year 2022
Lead investments 3
Follow on index 0.12
Exits 2
Group Appearance index 0.12

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Myosana Therapeutics

Biotechnology
Therapeutics
$5M07 Dec 2022 Seattle, Washington, United States
Crunchbase icon

Content report

The following text will be sent to our editors: